Protect Drug Innovation Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Protect Drug Innovation Act
This bill repeals several programs and requirements that were enacted under the Inflation Reduction Act of 2022 relating to the prices of prescription drugs, including (1) the Medicare Drug Price Negotiation Program, (2) provisions that require drug manufacturers to issue rebates for certain drugs under Medicare for which prices increase faster than inflation, and (3) provisions that cap annual out-of-pocket spending under the Medicare prescription drug benefit.
Read twice and referred to the Committee on Finance.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 4953: Protect Drug Innovation Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-4953/
"S. 4953: Protect Drug Innovation Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4953/.
S. 4953, 117th Cong. (2026), https://openamerica.io/bill/117-S-4953/.
[S. 4953: Protect Drug Innovation Act](https://openamerica.io/bill/117-S-4953/)